Three Rheumatologic Diseases, One FDA-Approved Option to Consider for Appropriate Patients, From Juveniles to Adults
Exhibit Hall, Innovation Theater B
Developed and offered by Sanofi Pharmaceuticals (Non-CME)
Loading view.
- There are no upcoming events.
- There are no upcoming events.
Innovation Theater
Latest Past Events
Featured
Beyond the Basics: What Makes Immunoglobulin Therapy Effective in Dermatomyositis?
Exhibit Hall, Innovation Theater A
Developed and offered by Octapharma (Non-CME)
Expert Perspectives: Identification and Management of Eosinophilic Granulomatosis with Polyangiitis
Exhibit Hall, Innovation Theater B
Developed and offered by GSK
Upcoming Featured Industry Events
Popular Articles
-
Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease
-
ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists
-
FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases
-
Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice
-
Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology